Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:OYST Oyster Point Pharma (OYST) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis Get Oyster Point Pharma alerts: Email Address About Oyster Point Pharma Stock (NASDAQ:OYST) 30 days 90 days 365 days Advanced Chart Ad Investors AlleyForget Trump and KamalaForget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now.Download my Dividend Calendar here Get Oyster Point Pharma alerts:Sign Up Key Stats Today's Range$11.17▼$11.1750-Day Range$11.08▼$11.2052-Week Range$3.46▼$19.00Volume330 shsAverage Volume212,171 shsMarket Capitalization$299.85 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewOyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also developing TYRVAYA that is in Phase II clinical trial for the treatment of for neurotrophic keratopathy. The company was incorporated in 2015 and is headquartered in Princeton, New Jersey.Read More… Forget Trump and Kamala (Ad)Forget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now.Download my Dividend Calendar here Receive OYST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oyster Point Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address OYST Stock News HeadlinesEyePoint Pharmaceuticals: A Buy Rating Backed by DURAVYU’s Potential and Positive Clinical TrialsSeptember 16, 2024 | markets.businessinsider.comItaly oyster farmers dream of pearls from warming MediterraneanSeptember 10, 2024 | reuters.comOur #1 Ticker for the Rare "Retirement Window"We've only seen this happen three times in the past 20 years... And every time - like clockwork - it's minted an entire new class of millionaires.September 20, 2024 | Behind the Markets (Ad)As remote working keeps rolling, Oyster raises $59M Series D at $1.2B valuationSeptember 4, 2024 | msn.comNew Trend Of Pharma Selling Directly To Consumers Raises QuestionsSeptember 4, 2024 | forbes.comEyePoint Pharmaceuticals: After A Tough 2024 To Date, Is It Time To 'Buy The Dip' (Rating Upgrade)August 30, 2024 | seekingalpha.comSerbia looks to reset ties with US, Israel with first Jewish FM Marko Djuric - interviewAugust 17, 2024 | msn.comThe Oyster Hut to open first brick-and-mortar location in Louise, TexasAugust 15, 2024 | chron.comSee More Headlines OYST Stock Analysis - Frequently Asked Questions How were Oyster Point Pharma's earnings last quarter? Oyster Point Pharma, Inc. (NASDAQ:OYST) announced its quarterly earnings results on Thursday, November, 4th. The company reported ($0.68) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.16) by $0.48. The business had revenue of $17.94 million for the quarter. Oyster Point Pharma had a negative net margin of 901.99% and a negative trailing twelve-month return on equity of 490.33%. When did Oyster Point Pharma IPO? Oyster Point Pharma (OYST) raised $85 million in an initial public offering on Thursday, October 31st 2019. The company issued 5,000,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, Cowen and Piper Jaffray served as the underwriters for the IPO. What other stocks do shareholders of Oyster Point Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Oyster Point Pharma investors own include OPKO Health (OPK), Pfizer (PFE), Akero Therapeutics (AKRO), Walt Disney (DIS), Energy Transfer (ET), Fulcrum Therapeutics (FULC) and Johnson & Johnson (JNJ). Company Calendar Last Earnings11/04/2021Today9/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:OYST CUSIPN/A CIK1720725 Webwww.oysterpointrx.com Phone609-382-9032FaxN/AEmployees303Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($6.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-100,660,000.00 Net Margins-901.99% Pretax Margin-901.99% Return on Equity-490.33% Return on Assets-108.29% Debt Debt-to-Equity Ratio8.49 Current Ratio3.35 Quick Ratio3.11 Sales & Book Value Annual Sales$24.54 million Price / Sales12.22 Cash FlowN/A Price / Cash FlowN/A Book Value$3.80 per share Price / Book2.94Miscellaneous Outstanding Shares26,844,000Free Float22,039,000Market Cap$299.85 million OptionableNot Optionable Beta1.31 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:OYST) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oyster Point Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oyster Point Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.